rs56024577

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001244008.2(KIF1A):​c.3641-8C>T variant causes a splice region, intron change. The variant allele was found at a frequency of 0.279 in 1,543,814 control chromosomes in the GnomAD database, including 66,318 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.24 ( 5486 hom., cov: 33)
Exomes 𝑓: 0.28 ( 60832 hom. )

Consequence

KIF1A
NM_001244008.2 splice_region, intron

Scores

2
Splicing: ADA: 0.0003042
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 3.72
Variant links:
Genes affected
KIF1A (HGNC:888): (kinesin family member 1A) The protein encoded by this gene is a member of the kinesin family and functions as an anterograde motor protein that transports membranous organelles along axonal microtubules. Mutations at this locus have been associated with spastic paraplegia-30 and hereditary sensory neuropathy IIC. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Apr 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 2-240741385-G-A is Benign according to our data. Variant chr2-240741385-G-A is described in ClinVar as [Benign]. Clinvar id is 129391.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-240741385-G-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.467 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KIF1ANM_001244008.2 linkc.3641-8C>T splice_region_variant, intron_variant Intron 34 of 48 ENST00000498729.9 NP_001230937.1 Q12756-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KIF1AENST00000498729.9 linkc.3641-8C>T splice_region_variant, intron_variant Intron 34 of 48 5 NM_001244008.2 ENSP00000438388.1 Q12756-3

Frequencies

GnomAD3 genomes
AF:
0.235
AC:
35771
AN:
152008
Hom.:
5473
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0604
Gnomad AMI
AF:
0.170
Gnomad AMR
AF:
0.346
Gnomad ASJ
AF:
0.234
Gnomad EAS
AF:
0.431
Gnomad SAS
AF:
0.484
Gnomad FIN
AF:
0.335
Gnomad MID
AF:
0.278
Gnomad NFE
AF:
0.270
Gnomad OTH
AF:
0.240
GnomAD3 exomes
AF:
0.347
AC:
57808
AN:
166444
Hom.:
11293
AF XY:
0.352
AC XY:
31512
AN XY:
89606
show subpopulations
Gnomad AFR exome
AF:
0.0590
Gnomad AMR exome
AF:
0.509
Gnomad ASJ exome
AF:
0.247
Gnomad EAS exome
AF:
0.453
Gnomad SAS exome
AF:
0.483
Gnomad FIN exome
AF:
0.364
Gnomad NFE exome
AF:
0.277
Gnomad OTH exome
AF:
0.312
GnomAD4 exome
AF:
0.284
AC:
395390
AN:
1391688
Hom.:
60832
Cov.:
30
AF XY:
0.291
AC XY:
199666
AN XY:
686874
show subpopulations
Gnomad4 AFR exome
AF:
0.0524
Gnomad4 AMR exome
AF:
0.482
Gnomad4 ASJ exome
AF:
0.244
Gnomad4 EAS exome
AF:
0.424
Gnomad4 SAS exome
AF:
0.478
Gnomad4 FIN exome
AF:
0.339
Gnomad4 NFE exome
AF:
0.264
Gnomad4 OTH exome
AF:
0.281
GnomAD4 genome
AF:
0.235
AC:
35797
AN:
152126
Hom.:
5486
Cov.:
33
AF XY:
0.247
AC XY:
18348
AN XY:
74372
show subpopulations
Gnomad4 AFR
AF:
0.0603
Gnomad4 AMR
AF:
0.347
Gnomad4 ASJ
AF:
0.234
Gnomad4 EAS
AF:
0.431
Gnomad4 SAS
AF:
0.484
Gnomad4 FIN
AF:
0.335
Gnomad4 NFE
AF:
0.270
Gnomad4 OTH
AF:
0.248
Alfa
AF:
0.202
Hom.:
698
Bravo
AF:
0.227
Asia WGS
AF:
0.438
AC:
1519
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Genetic Services Laboratory, University of Chicago
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Hereditary spastic paraplegia 30 Benign:2
Aug 19, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Mar 03, 2015
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Hereditary spastic paraplegia Benign:1
Dec 12, 2016
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Neuropathy, hereditary sensory, type 2C Benign:1
Aug 19, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Intellectual disability, autosomal dominant 9 Benign:1
Aug 19, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Neuropathy, hereditary sensory, type 2C;C5235139:Hereditary spastic paraplegia 30;C5393830:Intellectual disability, autosomal dominant 9 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
5.8
DANN
Benign
0.53

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00030
dbscSNV1_RF
Benign
0.0080
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs56024577; hg19: chr2-241680802; COSMIC: COSV57484858; COSMIC: COSV57484858; API